However, tumors can interfere with the IFNAR pathway to maintain their own survival, and tumors that do not respond to IFNAR signaling may require other therapeutic strategies to promote adequate type I IFN secretion into the tumor microenvironment. Here, IFNAR1 is linked to neoplasm.